HCA Healthcare (HCA) – Investment Analysts’ Recent Ratings Updates

HCA Healthcare (NYSE: HCA) has recently received a number of price target changes and ratings updates:

  • 11/26/2018 – HCA Healthcare was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $151.00 price target on the stock. According to Zacks, “HCA Healthcare’s shares have outperformed its industry’s gain in a year’s time.  Its top line has been growing over the last several quarters on higher admissions as well as improved payor and service mix. A number of acquisitions helped the company gain a strong foothold in the industry, fueling its inorganic growth. The company has also raised its guidance from its previous projections. A strong balance sheet and free cash flow are a couple of other positives for the company. The company's third quarter earnings of $2.16 per share, surpassed the Zacks Consensus Estimate by 11.9%, led by higher same facility admissions. However, its high operating expenses continue to weigh on the margins. The company would continue to incur debts for future acquisitions, which is a concern.”
  • 11/20/2018 – HCA Healthcare was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “HCA Healthcare’s shares have outperformed its industry’s gain in a year’s time.  Its top line has been growing over the last several quarters on higher admissions as well as improved payor and service mix. A number of acquisitions helped the company gain a strong foothold in the industry, fueling its inorganic growth. The company has also raised its guidance from its previous projections. A strong balance sheet and free cash flow are a couple of other positives for the company. The company's third quarter earnings of $2.16 per share, surpassed the Zacks Consensus Estimate by 11.9%, led by higher same facility admissions. However, its high operating expenses continue to weigh on the margins. The company would continue to incur debts for future acquisitions, which is a concern.”
  • 11/19/2018 – HCA Healthcare was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $157.00 price target on the stock. According to Zacks, “HCA Healthcare’s shares have outperformed its industry’s gain in a year’s time.  Its top line has been growing over the last several quarters on higher admissions as well as improved payor and service mix. A number of acquisitions helped the company gain a strong foothold in the industry, fueling its inorganic growth. The company has also raised its guidance from its previous projections. A strong balance sheet and free cash flow are a couple of other positives for the company. The company's third quarter earnings of $2.16 per share, surpassed the Zacks Consensus Estimate by 11.9%, led by higher same facility admissions. However, its high operating expenses continue to weigh on the margins. The company would continue to incur debts for future acquisitions, which is a concern.”
  • 11/15/2018 – HCA Healthcare is now covered by analysts at UBS Group AG. They set a “buy” rating and a $162.00 price target on the stock.
  • 11/14/2018 – HCA Healthcare was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “HCA Healthcare’s shares have outperformed its industry’s gain in a year’s time.  Its top line has been growing over the last several quarters on higher admissions as well as improved payor and service mix. A number of acquisitions helped the company gain a strong foothold in the industry, fueling its inorganic growth. The company has also raised its guidance from its previous projections. A strong balance sheet and free cash flow are a couple of other positives for the company. However, its high operating expenses continue to weigh on the margins. The company would continue to incur debts for future acquisitions, which is a concern. The company's third quarter earnings of $2.16 per share, surpassed the Zacks Consensus Estimate by 11.9%, led by higher same facility admissions.”
  • 11/6/2018 – HCA Healthcare had its price target raised by analysts at Argus from $150.00 to $155.00. They now have a “buy” rating on the stock.
  • 11/1/2018 – HCA Healthcare had its price target raised by analysts at Credit Suisse Group AG from $156.00 to $165.00. They now have an “outperform” rating on the stock.
  • 10/31/2018 – HCA Healthcare had its price target raised by analysts at Jefferies Financial Group Inc from $155.00 to $158.00. They now have a “buy” rating on the stock.
  • 10/11/2018 – HCA Healthcare had its price target raised by analysts at Citigroup Inc from $136.00 to $156.00. They now have a “buy” rating on the stock.

NYSE:HCA opened at $135.51 on Tuesday. HCA Healthcare Inc has a 52-week low of $76.48 and a 52-week high of $144.96. The stock has a market cap of $46.44 billion, a PE ratio of 20.56, a P/E/G ratio of 1.18 and a beta of 0.48.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Tuesday, October 30th. The company reported $2.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.93 by $0.23. HCA Healthcare had a net margin of 6.82% and a negative return on equity of 73.71%. The company had revenue of $11.45 billion for the quarter, compared to the consensus estimate of $11.29 billion. During the same quarter in the previous year, the firm posted $1.13 EPS. The business’s revenue was up 7.1% compared to the same quarter last year. On average, equities research analysts forecast that HCA Healthcare Inc will post 9.34 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 28th. Stockholders of record on Monday, December 3rd will be issued a dividend of $0.35 per share. The ex-dividend date of this dividend is Friday, November 30th. This represents a $1.40 annualized dividend and a dividend yield of 1.03%. HCA Healthcare’s payout ratio is 21.24%.

In other news, SVP Jane D. Englebright sold 5,081 shares of the business’s stock in a transaction dated Friday, November 9th. The shares were sold at an average price of $141.90, for a total transaction of $720,993.90. Following the transaction, the senior vice president now owns 16,504 shares in the company, valued at approximately $2,341,917.60. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Deborah M. Reiner sold 723 shares of HCA Healthcare stock in a transaction dated Monday, November 5th. The shares were sold at an average price of $135.06, for a total transaction of $97,648.38. Following the sale, the senior vice president now owns 6,184 shares in the company, valued at $835,211.04. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 16,763 shares of company stock worth $2,346,147. Insiders own 2.80% of the company’s stock.

Institutional investors have recently modified their holdings of the company. Bamco Inc. NY acquired a new stake in shares of HCA Healthcare during the 3rd quarter valued at about $169,000. Glenmede Trust Co. NA boosted its position in shares of HCA Healthcare by 164.9% during the 3rd quarter. Glenmede Trust Co. NA now owns 1,274 shares of the company’s stock valued at $176,000 after acquiring an additional 793 shares in the last quarter. Signet Financial Management LLC acquired a new stake in shares of HCA Healthcare during the 2nd quarter valued at about $137,000. Smithfield Trust Co. boosted its position in shares of HCA Healthcare by 41.2% during the 3rd quarter. Smithfield Trust Co. now owns 1,405 shares of the company’s stock valued at $196,000 after acquiring an additional 410 shares in the last quarter. Finally, First Light Asset Management LLC acquired a new stake in shares of HCA Healthcare during the 3rd quarter valued at about $210,000. Institutional investors and hedge funds own 71.97% of the company’s stock.

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Story: What is a conference call?

Receive News & Ratings for HCA Healthcare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply